The 14 most recent market catalysts affecting $NUWE, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 17, 2026
Corporate Catalyst
Bullish
Impact 75
Nuwellis shares are trading higher after the company announced continued commercial momentum for its Aquadex SmartFlow system, with 31 consoles sold year-to-date in 2026.
The headline signals robust commercial execution for Nuwellis's flagship product, the Aquadex SmartFlow system. Selling 31 consoles year-to-date in 2026 suggests strong demand and …
Sep 17, 2026
Corporate Catalyst
Bullish
Impact 75
Nuwellis Says 31 Aquadex SmartFlow Consoles Sold Year-To-Date In 2026, Exceeding Full-Year Totals In Seven Of Past 10 Years; Reiterates 26% U.S. Revenue Growth In First Half
This headline is a significant positive catalyst for Nuwellis (NUWE). Exceeding full-year sales totals for 7 of the past 10 years just a few months into 2026, coupled with a reiter…
Sep 9, 2026
Corporate Catalyst
Bullish
Impact 75
Nuwellis Says Financial Efficiency Strategy Drove Q2 2026 Gross Margin To 76% From 56%; Says It Had About $8.8M In Cash As Of August 31, With Runway Into Q3 2027
This headline is a strong positive catalyst for Nuwellis (NUWE). The dramatic increase in gross margin from 56% to 76% demonstrates effective cost management and potentially improv…
Aug 13, 2026
Corporate Catalyst
Bearish
Impact 75
Nuwellis Q2 EPS $(26.64) Misses $(0.68) Estimate, Sales $1.969M Miss $2.415M Estimate
The headline reveals a substantial miss on both earnings per share (EPS) and sales estimates for Nuwellis (NUWE) in Q2. An EPS of $(26.64) against an estimate of $(0.68) is an enor…
Aug 4, 2026
Corporate Catalyst
Bullish
Impact 75
Nuwellis shares are trading higher after the company announced strategic development initiatives to expand the capabilities of its Aquadex SmartFlow System into a broader extracorporeal therapy platform.
This headline indicates a significant corporate catalyst for Nuwellis. By expanding the Aquadex SmartFlow System into a broader extracorporeal therapy platform, Nuwellis is signali…
Aug 4, 2026
Corporate Catalyst
Bullish
Impact 65
Nuwellis Expanding Capabilities Of Aquadex SmartFlow System Into Broader Extracorporeal Therapy Platform
Nuwellis is expanding the capabilities of its Aquadex SmartFlow System, a key product, to support a wider range of extracorporeal therapies. This is significant because it moves th…
Jul 31, 2026
Corporate Catalyst
Bearish
Impact 75
Nuwellis shares are trading lower after the company announced the pricing of its $3.4 million offering of 1,310,890 shares at $2.59 per share.
The primary impact of this headline is negative for Nuwellis (NUWE) due to the dilution of existing shares and the offering being priced at a discount. This type of capital raise o…
Jul 31, 2026
Corporate Catalyst
Neutral
Impact 65
Nuwellis Announces Registered Direct Offering Of 1,310,890 Shares At $2.59 Per Share
This registered direct offering by Nuwellis is a corporate catalyst, specifically a capital raise. The issuance of new shares at $2.59, likely below the market price prior to the a…
Jul 30, 2026
Market Technicals
Bullish
Impact 55
12 Health Care Stocks Moving In Thursday's Intraday Session
This filing is a summary of intraday stock movements for various healthcare companies, with several experiencing gains over 25% and others declines over 20%. The primary drivers me…
Jul 30, 2026
Corporate Catalyst
Bullish
Impact 75
Nuwellis shares are trading higher after the company announced the acceptance of a new single-center retrospective study in Frontiers in Pediatrics.
The acceptance of a new single-center retrospective study in a peer-reviewed journal like 'Frontiers in Pediatrics' is a significant positive for Nuwellis. It provides clinical val…
Jul 30, 2026
Market Technicals
Bullish
Impact 55
12 Health Care Stocks Moving In Thursday's Pre-Market Session
This Benzinga article, presented as an 8-K filing, details the pre-market performance of 12 healthcare stocks. The significant price movements, both positive and negative, are prim…
Jul 30, 2026
Corporate Catalyst
Bullish
Impact 85
Nuwellis (NUWE) Stock Rallies 90% After Hours: Here's Why it is Trending
Nuwellis (NUWE) experienced a significant after-hours rally following two key announcements. First, the company expanded its Aquadex SmartFlow system into a leading pediatric hospi…
Jul 14, 2026
Corporate Catalyst
Neutral
Impact 55
Nuwellis Granted U.S. Patent No. 12678592 B2 For "DUAL LUMEN CATHETER"
Nuwellis (NUWE) announced the grant of a U.S. patent for a dual lumen catheter, which is a positive development for the company. This patent strengthens Nuwellis's intellectual pro…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.